How EGF and TGF-α Affect EGF-Receptor in Prostate Cancer Cells
Author Information
Author(s): Seth D, Shaw K, Jazayeri J, Leedman P J
Primary Institution: Laboratory for Cancer Medicine and University Department of Medicine, Royal Perth Hospital, Perth, Western Australia, 6001, Australia
Hypothesis
The study investigates the molecular mechanisms involved in the regulation of EGFR expression by EGF and TGF-α in human prostate cancer cells.
Conclusion
The study reveals that EGF and TGF-α regulate EGFR mRNA and protein levels in complex ways across different prostate cancer cell lines.
Supporting Evidence
- TGF-α stabilized EGFR mRNA two- to threefold in all three cell lines.
- EGF stabilized EGFR mRNA approximately twofold in LNCaP and DU145 cells, but not in PC3 cells.
- Both ligands increased EGFR transcription in LNCaP and DU145 cells.
- EGF reduced total EGFR protein levels more than TGF-α.
- EGF shortened EGFR protein stability, leading to rapid disappearance of newly synthesized EGFR protein.
Takeaway
This study looks at how two substances, EGF and TGF-α, help control a protein that is important for prostate cancer cells to grow.
Methodology
The study examined three human prostate cancer cell lines to analyze the effects of EGF and TGF-α on EGFR expression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website